Jump to navigation
N4 Pharma
Home
About
Experienced Board
Nigel Theobald
Paul Titley
Dr David Templeton
Luke Cairns
Our business
Our history
Our model
Generics
Vaccines
Patents
Pipeline
Sildenafil
Nuvec
Aprepitant
Sartans
Single dose Hep B
Duoloxetine
Investors
AIM Rule 26
AIM Securities Information
Advisers
Corporate Governance and Director Responsibilities
Investor Information
Company Reports
N4 Pharma Investor Presentation
Regulatory News
Other News
Contact Us
Investors
Back to top
Investor Information
Regulatory News
AIM Rule 26